DHA Clinical Pharmacy Service Line Kevin W. Roberts, COL, MS - - PowerPoint PPT Presentation

dha clinical pharmacy service line
SMART_READER_LITE
LIVE PREVIEW

DHA Clinical Pharmacy Service Line Kevin W. Roberts, COL, MS - - PowerPoint PPT Presentation

DHA Clinical Pharmacy Service Line Kevin W. Roberts, COL, MS Pharmacy Consultant to the USA Surgeon General Director, USA Pharmacy Service Line CPE Information and Disclosures Kevin W. Roberts declares no conflicts of interest, real or


slide-1
SLIDE 1

DHA Clinical Pharmacy Service Line

Kevin W. Roberts, COL, MS Pharmacy Consultant to the USA Surgeon General Director, USA Pharmacy Service Line

slide-2
SLIDE 2

The American Pharmacist Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Kevin W. Roberts declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

CPE Information and Disclosures

slide-3
SLIDE 3

 Target Audience: Pharmacists and Pharmacy Technicians  ACPE#: 0202-0000-18-207-L04-P/T  Activity Type: Knowledge-based

CPE Information

slide-4
SLIDE 4

Learning Objectives

  • 1. Define the strategic pillars associated with the Army Pharmacy

strategic plan.

  • 2. Discuss the ways your MTF has implemented practices to achieve

strategic objectives and actions to date.

  • 3. Describe new specific strategic plan objectives and actions that

impact your pharmacy practice as a staff member/pharmacy leader.

  • 4. Discuss measures of performance and effect that are related to your

pharmacy practice.

slide-5
SLIDE 5

Self-Assessment Questions

 1.

Which of the following is a measure of performance that supports the DHA Clinical Pharmacy Service Line:

 a.

Wait time

 b.

National Contract Compliance

 c.

RVU's/FTE

 d.

B2G

 d.

All the above

 e.

None of the above

slide-6
SLIDE 6

OUTLINE

 BACKGROUND  CPSL AREAS OF INTEREST  CPSL FOCUS  MILESTONES  MEASURES OF PERFORMANCE/EFFECT  DHA CPSL WORK GROUP  CLOSING REMARKS

slide-7
SLIDE 7

BACKGROUND--MHS Operating Model Purpose Statement

To enable front line clinicians t o drive Ent erprise-wide performance improvement s in readiness and healt h; empower Ent erprise-level Clinical Communit ies t o creat e condit ions for high reliabilit y at t he point of care (processes, st andards, met rics); and hold ourselves account able t o MHS st andards and clinical out comes.

slide-8
SLIDE 8

BACKGROUND

slide-9
SLIDE 9

BACKGROUND

  • The Clinical Pharmacy Service Line (CPSL) is one of three lines of effort utilized by the

DHA Pharmacy Operations Division to improve provision of healthcare within the MHS.

  • Purpose: The Clinical Pharmacy Service Line will enhance readiness, improve health, and

lower costs of care through optimized provision of pharmaceutical care.

  • Established multi-service workgroup in May 2018
  • Goals
  • Standardize manning, processes and accounting of clinical pharmacy services.
  • Collaborative development with best practices (to include Services, VA and Public Health)
  • Guide/develop DHA foundational publications
slide-10
SLIDE 10

CPSL Areas of Interest

  • Coding
  • Reporting
  • Staffing
  • Civilian PD’s
  • Credentialing and Privileging
  • Metrics (performance/effectiveness)
  • Training and Competency Assessment
  • Ready Medical Force/Medically Ready Force
  • Analytics Team
slide-11
SLIDE 11

CPSL FOCUS

  • Coding: Identified significant variance among services
  • Engaged DHA coding work group
  • Ultimate goal: DHA instruction manual
  • Resources
  • Personnel
  • Clinical Pharmacists (1:6,500 Prime Enrollees)
  • Clinical Technicians
  • Interventional Software
  • Position Standardization
  • Various position descriptions being consolidated
  • Position/Pay parity
slide-12
SLIDE 12

CPSL FOCUS

  • Measures of Performance
  • RVU’s/FTE
  • % patient care time/RVU
  • Measures of Effect
  • Disease specific
  • Quality
  • Readiness
  • Polypharmacy
  • Potentially deployment limiting medication
slide-13
SLIDE 13

CPSL FY19 MILESTONES

  • Provide resource requirements to Director, DHA POD by 1 October 2018.
  • Establish a Service Member readiness metric by 1 October 2018 (Army Lead)
  • Establish DHA CPSL PI by 31 March 2019 (Air Force Lead)
  • Submit standard PD’s by 31 March 2019 (Navy Lead)
  • Establish standard credentialing/privileging process by 31 March 2019
slide-14
SLIDE 14

DHA’s Clinical Pharmacy Service Line Work Group

 1.

Which of the following is a measure of performance reflected in the DHA Clinical Pharmacy Service Line:

 a.

Wait time

 b.

National Contract Compliance

 c.

RVU's/FTE

 d.

B2G

 d.

All the above

 e.

None of the above

slide-15
SLIDE 15

DHA’s CPSL Work Group

COL Kevin Roberts, (co-chair/consultant champion), USA

Col Melissa Howard (co-chair/consultant champion), USAF

  • Dr. David Meade (co-chair), DHA

COL Jeff Neigh, USA

  • Dr. Jennifer Evans, DAC, USA

LtCol Heather Fenzl, USAF LtCol Julie Meek, USAF Maj Sokunthea Peou, USAF CDR Janel Rossetto, USN LCDR Reina Gomez, USN

  • Dr. Alexandra Vance, DAC, USN

LTC(P) Mark Maneval, USA, DHA CDR Thien Nguyen, USPHS, DHA

  • Dr. Ingrid Svihla, DAC, DHA
slide-16
SLIDE 16

Closing Remarks

Kevin W. Roberts, COL, MS Pharmacy Consultant to The USA Surgeon General Director, USA Pharmacy Service Line

(kevin.w.roberts18.mil@mail.mil/703-681-5959)

slide-17
SLIDE 17

“ One Team – One Purpose, Conserving the Fighting S trength”